While the inhibitory receptor SIGIRR is shut down in tumor cells, the expression of the activatory IL1R1 is maintained (data not shown), and we next asked if SIGIRR downregulation may unleash intrinsic IL1 signaling in RCC cells. This evidence concerns the gene IL1B and renal cell carcinoma.